254267788	254267788	CD	B-NP	O
|	|	NN	I-NP	O
SCHCOC	SCHCOC	NN	I-NP	O
|	|	NN	I-NP	O
70537348	70537348	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3677521	3677521	CD	B-NP	O
|	|	CC	I-NP	O
6/26/2003	6/26/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/23/2003	4/23/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/26/2003	1/26/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
OESTERLING	OESTERLING	NNP	B-NP	O
,	,	,	O	O
VINCENT	VINCENT	NNP	B-NP	O
G	G	NNP	I-NP	O
JONATHON	JONATHON	NNP	I-NP	O
179-06-78-1	179-06-78-1	NN	I-NP	O
Renchi	Renchi	NNP	I-NP	O
Burgprowau	Burgprowau	NNP	I-NP	O
Beach	Beach	NNP	I-NP	O
,	,	,	O	O
Service	Service	NNP	B-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/7/03	10/7/03	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MARDINI	MARDINI	NNP	B-NP	O
,	,	,	O	O
EZRA	EZRA	NNP	B-NP	O
DEWAYNE	DEWAYNE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
;	;	:	O	O
5	5	CD	B-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
PO	PO	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/3/03	4/3/03	CD	B-NP	O
by	by	IN	B-PP	O
STILLWAGON	STILLWAGON	NNP	B-NP	O
,	,	,	O	O
DEVIN	DEVIN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
72637420	72637420	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MVI	MVI	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
PROSCAR	PROSCAR	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
FINASTERIDE	FINASTERIDE	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
BISOPROLOL	BISOPROLOL	NN	I-NP	O
FUMARATE	FUMARATE	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	B-ADJP	O
90	90	CD	B-NP	O
;	;	:	O	O
HR	HR	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
HUMALOG	HUMALOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0	0	CD	I-NP	O
CFU	CFU	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
use	use	NN	B-NP	O
scale	scale	NN	I-NP	O
for	for	IN	B-PP	O
fsbg	fsbg	NN	B-NP	O
120-130	120-130	CD	I-NP	O
2u	2u	CD	I-NP	O
;	;	:	O	O
130-140	130-140	CD	B-NP	O
3u	3u	CD	I-NP	O
;	;	:	O	O
140-150	140-150	CD	B-NP	O
4u	4u	CD	I-NP	O
;	;	:	O	O
150-160	150-160	CD	B-NP	O
5u	5u	CD	I-NP	O
;	;	:	O	O
160-170	160-170	CD	B-NP	O
6u	6u	CD	I-NP	O
;	;	:	O	O
170-180	170-180	CD	B-NP	O
7u	7u	CD	I-NP	O
;	;	:	O	O
180-190	180-190	CD	B-NP	O
8u	8u	CD	I-NP	O
;	;	:	O	O
190-200	190-200	CD	B-NP	O
10u	10u	CD	I-NP	O
;	;	:	O	O
200-210	200-210	CD	B-NP	O
12u	12u	CD	I-NP	O
;	;	:	O	O
210-220	210-220	CD	B-NP	O
13u	13u	CD	I-NP	O
;	;	:	O	O
220-230	220-230	CD	B-NP	O
14u	14u	CD	I-NP	O
;	;	:	O	O
>	>	SYM	B-NP	O
230	230	CD	B-NP	O
15u	15u	CD	I-NP	O
and	and	CC	O	O
page	page	NN	B-NP	B-protein
HO	HO	NN	I-NP	I-protein
PLAVIX	PLAVIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
LANTUS	LANTUS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
10/5	10/5	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
WELCHOL	WELCHOL	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
COLESEVELAM	COLESEVELAM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/23/03	8/23/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
dose	dose	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Nystrom	Nystrom	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Badgett	Badgett	NNP	I-NP	O
-	-	:	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
schedule	schedule	VB	I-VP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
11/4/03	11/4/03	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Nave	Nave	NNP	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Iv	Iv	NN	B-NP	O
contrast	contrast	NN	I-NP	O
dyes	dye	VBZ	B-VP	O
ADMIT	ADMIT	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
cad	cad	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
mi	mi	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cabg	cabg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pvd	pvd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
femoral	femoral	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
femoral	femoral	JJ	I-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterol	hypercholesterol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
afib	afib	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
left	leave	VBD	B-VP	O
heart	heart	NN	B-NP	O
catheterization	catheterization	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
y/o	y/o	NN	I-NP	O
man	man	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
s/p	s/p	NN	I-NP	O
CABGx2	CABGx2	NN	I-NP	O
,	,	,	O	O
PCI	PCI	NN	B-NP	B-protein
in	in	IN	B-PP	O
8/17	8/17	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
afib	afib	NN	B-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
after	after	IN	B-PP	O
abnl	abnl	NN	B-NP	O
dobutamine-MRI	dobutamine-MRI	NN	I-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
in	in	IN	B-PP	O
8/17	8/17	CD	B-NP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
angina	angina	NN	B-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
MRI	MRI	NN	I-NP	O
showed	show	VBD	B-VP	O
ischemia	ischemia	NN	B-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cath	cath	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
LMCA	LMCA	NN	B-NP	B-protein
and	and	CC	I-NP	O
SBG	SBG	NN	I-NP	B-protein
to	to	TO	B-PP	O
RtPDA	RtPDA	NN	B-NP	B-protein
stented	stente	VBD	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
had	have	VBD	B-VP	O
angina	angina	NN	B-NP	O
but	but	CC	O	O
increased	increase	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
and	and	CC	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/5/03	6/5/03	CD	B-NP	O
had	have	VBD	B-VP	O
elective	elective	JJ	B-NP	O
dobutamine-MRI	dobutamine-MRI	NN	I-NP	O
which	which	WDT	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
angina	angina	NN	B-NP	O
and	and	CC	I-NP	O
reversible	reversible	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
RCA/LCx	RCA/LCx	NN	B-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
but	but	CC	O	O
elevated	elevate	VBD	B-VP	O
INR	INR	NN	B-NP	B-protein
and	and	CC	O	O
rhonchorous	rhonchorous	JJ	B-ADJP	O
.	.	.	O	O

Admit	Admit	NN	B-NP	O
to	to	TO	B-PP	O
diurese	diurese	JJ	B-NP	O
and	and	CC	I-NP	O
reverse	reverse	JJ	I-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O

Exam	Exam	NNP	B-NP	O
:	:	:	O	O
rhonchi	rhonchus	NNS	B-NP	O
throughout	throughout	IN	B-PP	O
both	both	DT	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
+	+	SYM	B-VP	O
S2	S2	NN	B-NP	B-protein
+	+	SYM	I-NP	O
S3	S3	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	O
visible	visible	JJ	I-NP	O
+	+	SYM	I-NP	O
audible	audible	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
protuberant	protuberant	JJ	B-NP	O
abdomen	abdoman	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
femoral	femoral	JJ	B-NP	O
bruit	bruit	NN	I-NP	O
,	,	,	O	O
faint	faint	NN	B-NP	O
left	leave	VBD	B-VP	O
dp	dp	NN	B-NP	O
pulse	pulse	NN	I-NP	O
;	;	:	O	O
nonpalpable	nonpalpable	JJ	B-NP	O
r	r	NN	I-NP	O
dp	dp	NN	I-NP	O
pulse	pulse	NN	I-NP	O
.	.	.	O	O

Ext	Ext	JJ	B-NP	O
lukewarm	lukewarm	NN	I-NP	O
.	.	.	O	O

*****************************************	*****************************************	SYM	O	O
Ischemic	Ischemic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
bb	bb	NN	B-NP	O
,	,	,	O	O
wellchol	wellchol	NN	B-NP	O
,	,	,	O	O
ace	ace	NN	B-NP	O
.	.	.	O	O

Held	Held	JJ	B-NP	O
coumadin	coumadin	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
LHC	LHC	NN	B-NP	B-protein
as	as	IN	B-PP	O
supratherapeutic	supratherapeutic	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
afib	afib	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
gave	give	VBD	B-VP	O
1mg	1mg	NN	B-NP	O
vit	vit	NN	I-NP	O
K.	K.	NNP	I-NP	O
Catheterization	Catheterization	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
with	with	IN	B-PP	O
patent	patent	NN	B-NP	O
LM	LM	NN	I-NP	O
stent	stent	NN	I-NP	O
and	and	CC	I-NP	O
stent	stent	NN	I-NP	O
within	within	IN	B-PP	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
PLV	PLV	NN	B-NP	B-protein
graft	graft	NN	I-NP	I-protein
.	.	.	O	O

Concluded	Conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
symptoms	symptom	NNS	B-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Will	Will	MD	O	O
have	have	VBP	B-VP	O
future	future	JJ	B-NP	O
stress-imaging	stress-imaging	JJ	I-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
correlate	correlate	VB	I-VP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
:	:	:	O	O
Diuresed	Diurese	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
home	home	NN	B-NP	O
lasix	lasix	NN	I-NP	O
+	+	SYM	B-VP	O
lasix	lasix	NN	B-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

PCWP	PCWP	NN	B-NP	B-protein
26	26	CD	I-NP	I-protein
suggesting	suggest	VBG	B-VP	O
increasing	increase	VBG	B-VP	O
diuretic	diuretic	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
advisable	advisable	JJ	B-ADJP	O
.	.	.	O	O

Rhonchi	Rhonchi	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
considerably	considerably	RB	B-ADVP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

DM	DM	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
humalog	humalog	NN	I-NP	O
scale	scale	NN	I-NP	O
+	+	SYM	B-NP	O
lantus	lantus	NN	I-NP	O
combination	combination	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
effectively	effectively	RB	B-ADVP	O
for	for	IN	B-PP	O
glycemic	glycemic	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
contact	contact	NN	I-NP	O
PCP	PCP	NN	I-NP	O
if	if	IN	B-SBAR	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
>	>	SYM	B-VP	O
3lb	3lb	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Monitor	Monitor	NNP	B-NP	O
your	your	PRP$	B-NP	O
diet	diet	NN	I-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
salty	salty	NN	B-NP	O
foods	food	NNS	I-NP	O
and	and	CC	O	O
too	too	RB	B-NP	O
much	much	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
work	work	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
ideal	ideal	JJ	B-NP	O
diuretic	diuretic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Adjust	Adjust	RB	B-NP	O
diuretic	diuretic	JJ	I-NP	O
and	and	CC	I-NP	O
cardiac	cardiac	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
per	per	IN	B-PP	O
primary	primary	JJ	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Mcphillips	Mcphillips	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CLOPP	CLOPP	NN	B-NP	B-protein
,	,	,	O	O
CRISTOBAL	CRISTOBAL	NNP	B-NP	O
CHUNG	CHUNG	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HF81	HF81	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/7/03	10/7/03	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

